| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |